Recommendations on the utilization of telemedicine in cardiology

Gruska, M.; Aigner, Gerhard; Altenberger, Johann; Burkart-Küttner, Dagmar; Fiedler, Lukas; Gwechenberger, Marianne; Lercher, Peter; Martinek, Martin; Nürnberg, Michael; Pölzl, Gerhard; Porenta, Gerold; Sauermann, Stefan; Schukro, Christoph; Scherr, Daniel; Steinwender, Clemens; Stühlinger, Markus; Teubl, Alexander

doi:10.1007/s00508-020-01762-2

Cited by 14 publications

(13 citation statements)

References 79 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(The relationship between product counts and revenues and excise duty in relation to innovation activity are considered.) Excise tax and revenues 2 Gruska et al 24 III The article aims to provoke a critical discussion of the digital change in cardiology and to make recommendations for the implementation of those telemedical processes that have been shown to exert positive effects on a wide variety of medical and economic parameters. The authors consider cost-effectiveness, cost-benefit ratio , and costs reduction .…”

Section: Search Results On Regulation Innovation Economic Impact and Medical Devicementioning

confidence: 99%

“…Where the reviewed articles employ any methods of assessing the impact of regulations or meeting the conditions of regulations, especially in the case of HTA, it is usually the method of cost-effectiveness, the approach of cost per patient, or methods of cost-saving—eg Gruska et al 24 Wright et al 25 Heidt et al 26 and Plun-Favreau et al 27 On the other hand, Gelijns et al 28 emphasise that it is important to consider the specificity of pharmaceuticals and medical devices when using the cost-effectiveness method. It is not uncommon that shortly after the introduction of a medical devices, additional adjustments are made due to the “learning-by-using” effect.…”

Section: Search Results On Regulation Innovation Economic Impact and Medical Devicementioning

confidence: 99%

See 1 more Smart Citation

Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry

Mačí¹

2022

RMHP

View full text Add to dashboard Cite

Introduction The regulatory area is one that restricts human behaviour and opportunities, but it also allows the prevention of loss of property, health, or even life in various fields. Regulations provide the market with public confidence, which is extremely important in the field of innovative medical devices. The aim of this article is to analyse critical factors and economic methods for regulatory impact assessment in the medical device industry, to focus on the finances, processes, or innovation activity of organisations operating in the medical device sector. Methods The paper consists of a scoping review according to the PRISMA methodology of the available literature in Web of Science and Scopus database, whereby combing the keywords “regulation” AND “innovation” AND “medical device” AND “economic impact,” we obtained a set of 156 results in the form of English-written articles. The output was then limited to the period between 2011 and 2020. Finally, 23 papers were used based on the exclusion and inclusion criteria. Results The resulting challenges of the identified problems in particular are the amount of high-quality data available at an appropriate cost and the availability of a flexible notified body. There are also challenges specific to the situation, such as demands on the safety of medical devices for children. From a public expectations point of view, there is a continuing need to maintain the urgency of the balance between available innovation and safety. Discussion As for the methods of economic assessment in general, or methods for assessing the economic impact of regulations in particular, cost-effectiveness analysis is the most commonly used method for research and development, while internal rate of return is frequently used for the producers, and budget impact analysis is typically used for healthcare service providers. A non-financial indicator that is often discussed is the time demands associated with meeting compliance requirements. The time-to-market indicator is also often mentioned. Economic and financial topics are not discussed in depth, as the reviewed articles simply mention the generally high costs attendant on complying with regulations and obtaining certificates.

show abstract

Section: Search Results On Regulation Innovation Economic Impact and Medical Devicementioning

confidence: 99%

Section: Search Results On Regulation Innovation Economic Impact and Medical Devicementioning

confidence: 99%

Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry

Mačí¹

2022

RMHP

View full text Add to dashboard Cite

show abstract

“…The innovation potential of AI may lead to substantial changes in organizational procedures, and the management must consider the impact on all stakeholders and align with their priorities [104]. Examples of potential obstacles include lack of engagement among patients/users, resistance among healthcare workers, insufficient networks and processes, economic and legal factors, lack of political support, lack of knowledge, and safety and data protection [94,125].…”

Section: Discussionmentioning

confidence: 99%

Change Management and Digital Innovations in Hospitals of Five European Countries

et al. 2021

View full text Add to dashboard Cite

The objective of the paper is to evaluate the quality of systemic change management (CHM) and readiness for change in five Central European countries. The secondary goal is to identify trends and upcoming changes in the field of digital innovations in healthcare. The results show that all compared countries (regardless of their historical context) deal with similar CHM challenges with a rather similar degree of success. A questionnaire distributed to hospitals clearly showed that there is still considerable room for improvement in terms of the use of specific CHM tools. A review focused on digital innovations based on the PRISMA statement showed that there are five main directions, namely, data collection and integration, telemedicine, artificial intelligence, electronic medical records, and M-Health. In the hospital environment, there are considerable reservations in applying change management principles, as well as the absence of a systemic approach. The main factors that must be monitored for a successful and sustainable CHM include a clearly defined and widely communicated vision, early engagement of all stakeholders, precisely set rules, adaptation to the local context and culture, provision of a technical base, and a step-by-step implementation with strong feedback.

show abstract

“…For telemedicine to become truly anchored as a credible alternative to usual care [3], evidence of its added-value in terms of effectiveness and efficiency is essential. Today, more and more research is done on the evaluation of its effectiveness and efficiency.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of the Effectiveness of Telemedicine in the Management of Cardiovascular Diseases in Primary Health Care in Cameroon: An Interventional Study

Bediang

Nganou–Gnindjio

Kamga

et al. 2021

Studies in Health Technology and Informatics

View full text Add to dashboard Cite

Objective: This study aimed to evaluate the effectiveness of tele-expertise (tele-ECG) in primary health care in Cameroon for the management of patients with cardiovascular diseases or risk factors. Method: It is a controlled multicenter study carried out in Cameroon’s two health facilities where tele-ECG has been implemented (intervention centers) and two other where telemedicine has been not implemented (control centers). Patients having cardiovascular risk factors or diseases received usual primary health care in the control centers. In contrast, they received usual primary health care and could perform an ECG associated with cardiologists’ remote expertise (tele-ECG) in the intervention centers. The primary outcome was to evaluate the rate of patients’ access to an ECG test and to cardiologist’ expertise. Results and Discussion: Telemedicine is effective for the management of patients with cardiovascular diseases in primary health care. It could improve healthcare providers’ clinical processes, clinical outcomes of patients and their satisfaction.

show abstract

Recommendations on the utilization of telemedicine in cardiology

Cited by 14 publications

References 79 publications

Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry

Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry

Change Management and Digital Innovations in Hospitals of Five European Countries

Evaluation of the Effectiveness of Telemedicine in the Management of Cardiovascular Diseases in Primary Health Care in Cameroon: An Interventional Study

Contact Info

Product

Resources

About